Liver cancerMACA CANCER INFORMATION GUIDE
Understanding liver cancer.
What liver cancer is, how hepatitis B and other causes raise the risk, how it can be prevented and found early, and the treatments your care team may discuss with you.
What is liver cancer?
Liver cancer begins when cells in the liver grow out of control and form a tumour. This guide is about primary liver cancer, which means cancer that starts in the liver itself.
In adults, the most common type of primary liver cancer is hepatocellular carcinoma (HCC). It starts in the main cells of the liver, called hepatocytes. It often develops in a liver that has already been damaged over many years, for example by hepatitis B or hepatitis C.
How the liver works
The liver is a large organ on the right side of the upper abdomen (belly), under the ribs. You cannot live without it. It breaks down and stores nutrients from food, makes most of the proteins that help blood to clot, makes bile to help digest fat, and breaks down alcohol, medicines and other toxins.
Cancer that has spread to the liver
Cancer that starts somewhere else, such as the bowel, breast, pancreas or lung, and then spreads to the liver is not liver cancer. It is called secondary liver cancer or liver metastases. It is treated according to where it started: for example, lung cancer that has spread to the liver is treated as lung cancer. In much of Africa and Asia, primary liver cancer is more common than secondary liver cancer.
How common is liver cancer?
According to the International Agency for Research on Cancer (GLOBOCAN 2024 estimates), about 843,000 people worldwide were diagnosed with liver cancer in 2024 and about 732,000 died from it. It is the seventh most common cancer in the world but the third most common cause of cancer death, because it is so often found late. About 69,000 of those new cases were in Africa. It is more common in men than in women.
Signs and symptoms
Liver cancer often causes no symptoms in its early stages. Signs usually appear later and can include:
- Losing weight without trying
- Loss of appetite, or feeling very full after a small meal
- Nausea or vomiting
- Pain or swelling in the upper right side of the abdomen, or pain near the right shoulder blade
- A lump or feeling of fullness under the ribs on the right side (an enlarged liver) or the left side (an enlarged spleen)
- Swelling of the abdomen caused by a build-up of fluid (ascites)
- Yellowing of the skin and the whites of the eyes (jaundice)
- Itchy skin
- Fever
- Bruising or bleeding easily
These symptoms are often caused by other conditions, but they should always be checked, especially if you already have hepatitis B or cirrhosis.
Risk factors
Most liver cancers develop in a liver that has been damaged for a long time. Having a risk factor does not mean you will get liver cancer, and many people with these risk factors never do. Things that increase the risk include:
- Chronic hepatitis B: a long-term infection of the liver with the hepatitis B virus. It is the leading cause of liver cancer in Africa and Asia.
- Chronic hepatitis C: a long-term infection with the hepatitis C virus, which can also lead to cirrhosis and liver cancer.
- Cirrhosis: scarring of the liver caused by long-term damage, for example from hepatitis, heavy drinking or fatty liver disease. Most, but not all, people who develop liver cancer have some cirrhosis.
- Aflatoxins: poisons made by a mould that can grow on foods such as maize (corn), groundnuts (peanuts) and rice when they are stored in warm, damp conditions. Exposure is most common in sub-Saharan Africa, South-East Asia and China. The risk is higher still in people who also have hepatitis B or C.
- Heavy alcohol use: which can cause cirrhosis, and adds to the risk in people with hepatitis B or C.
- Fatty liver disease and type 2 diabetes: a build-up of fat in the liver, linked to excess body weight and diabetes, can lead to inflammation and scarring.
- Smoking: the risk rises the more and the longer a person smokes.
- Being male: men are more likely than women to develop liver cancer.
Hepatitis B in Africa
The World Health Organization (WHO) estimates that about 240 million people worldwide were living with chronic hepatitis B in 2024, including about 64 million in the WHO African Region. Most people do not feel ill when they are first infected, so many do not know they have it. In places where it is common, it is most often passed from mother to baby at birth. It can also spread through infected blood and body fluids, for example on unsterilised needles, and through sex.
Having hepatitis B is nothing to be ashamed of. In places where it is common, many people were infected at birth, long before they could do anything about it. Knowing your status is the first step to protecting your liver and your family.
Prevention and early detection
Many liver cancers can be prevented, because the main causes can be prevented or treated.
Hepatitis B vaccination
The hepatitis B vaccine is safe and gives nearly 100% protection against infection. WHO recommends that every baby has the first dose as soon as possible after birth, ideally within 24 hours (the birth dose), followed by two or three more doses. The birth dose protects babies from infection passed on during birth. Unvaccinated children and adults can also ask about the vaccine. Vaccinating babies against hepatitis B has been shown to lower their risk of liver cancer.
Testing and treatment for hepatitis
- Get tested: a simple blood test shows whether you have hepatitis B or C. WHO recommends testing all pregnant women for hepatitis B. If a mother has hepatitis B, antiviral medicine during pregnancy and the vaccine soon after birth help protect the baby.
- Hepatitis B treatment: not everyone with hepatitis B needs medicine straight away, but regular check-ups show when it is needed. Tablets such as tenofovir or entecavir keep the virus under control. They do not cure it, so most people take them for life, but they slow liver damage and can lower the risk of liver cancer.
- Hepatitis C treatment: there is no vaccine for hepatitis C, but a course of tablets lasting 12 to 24 weeks can cure more than 95% of people.
Food storage and aflatoxins
Aflatoxin mould grows on crops that are damp, damaged or stored in warm conditions. Drying grains and groundnuts properly, storing them in a dry, cool place away from insects, and throwing away any that look mouldy, discoloured or shrivelled all help to lower exposure.
Alcohol and a healthy liver
Limiting alcohol, not smoking, keeping to a healthy weight and managing diabetes all help protect the liver. If you have hepatitis B or C, drinking alcohol adds to the damage to your liver, so ask your care team for advice about alcohol.
Surveillance for people at high risk
Surveillance means regular check-ups to find liver cancer early, before it causes symptoms, in people at high risk. It is often advised for people with cirrhosis and for some people with chronic hepatitis B, even without cirrhosis. It usually means an ultrasound scan of the liver, often with an alpha-fetoprotein (AFP) blood test, about every six months. If you have hepatitis B or cirrhosis, ask your care team whether surveillance is right for you.
Types of liver cancer
- Hepatocellular carcinoma (HCC): starts in the hepatocytes, the main cells of the liver. It is by far the most common type in adults.
- Intrahepatic cholangiocarcinoma: starts in the small bile ducts inside the liver. About 10–20% of primary liver cancers are this type. It is often treated in a similar way to HCC.
- Fibrolamellar carcinoma: a rare type that usually affects people under 35. It is more often possible to remove with surgery than HCC.
- Angiosarcoma: a rare cancer of the blood vessels of the liver, linked to some chemicals such as vinyl chloride and arsenic.
- Hepatoblastoma: a very rare cancer that mainly affects children under four. About two in three children with it are treated successfully with surgery and chemotherapy.
Diagnosis
Your doctor will ask about your symptoms and any history of hepatitis, alcohol use or liver disease, and examine you for signs such as jaundice or a swollen abdomen. They may then arrange the following tests.
Blood tests
- Alpha-fetoprotein (AFP): a protein that is often raised in liver cancer. Many people with early liver cancer have a normal level, so it is used alongside scans, and to check how well treatment is working.
- Hepatitis B and C tests: to look for the infections that often cause liver damage.
- Liver function tests: to show how well the rest of your liver is working. This helps decide which treatments are safe for you.
Imaging tests
- Ultrasound: uses sound waves to make a picture of the liver. It is usually the first test.
- CT scan: a detailed X-ray scan that shows the size and position of tumours and whether the cancer has spread.
- MRI scan: uses magnets and radio waves to give detailed pictures of the liver and its blood vessels.
Biopsy
In a biopsy, a small sample of tissue is taken with a thin needle and examined under a microscope. For liver cancer, scans are sometimes clear enough that a biopsy is not needed. Your care team will explain whether you need one.
Stages and outlook
The stage describes how big the cancer is and how far it has spread. For liver cancer, doctors also look at how well the rest of the liver is working and at your general health, because these affect which treatments are safe. Most people with liver cancer have some damage to the rest of their liver.
How doctors describe the stage
- TNM staging: looks at the size and number of tumours and whether they have grown into blood vessels (T), spread to nearby lymph nodes (N) or spread to other parts of the body (M). These are combined into stages I to IV.
- Child-Pugh score: is not a cancer stage, but a measure of how well the liver is working, based on blood tests and signs such as fluid in the abdomen or confusion. It is graded A (working well), B or C (working poorly).
- Barcelona Clinic Liver Cancer (BCLC) system: is widely used to plan treatment. It combines the tumour, liver function and general health, and groups liver cancer as very early, early, intermediate or advanced.
What the stage means for treatment
- Early: one or a few small tumours in a liver that is working reasonably well. Surgery, a liver transplant or ablation may be possible, and these offer the best chance of long-term control.
- Intermediate: larger or more tumours that are still only in the liver but cannot be removed with surgery. Treatments delivered directly to the liver, such as chemoembolisation, are often used.
- Advanced: the cancer has grown into major blood vessels or spread outside the liver. Medicines aim to control the cancer and help you live longer and better.
- When the liver is working very poorly: the focus is on comfort and quality of life, because strong cancer treatments could do more harm than good.
Outlook
Outlook depends greatly on how early liver cancer is found. In England, for example, almost half of people diagnosed at stage 1 live at least four years, compared with almost 5 in 100 diagnosed at stage 4. In Africa, liver cancer is often found late and at a younger age. A study of more than 2,500 patients at 21 hospitals in Africa, including nine in Nigeria, found that outside Egypt the typical age at diagnosis was 46 years, hepatitis B was the leading cause, and only 3% of patients received treatment aimed at the cancer. Earlier diagnosis, through hepatitis testing and surveillance for people at high risk, is the most important way to improve this.
Treatment
Treatment depends on the size, number and position of the tumours, whether the cancer has spread, how well your liver is working, your general health and your own wishes. A team that may include liver specialists (hepatologists), surgeons, oncologists, radiologists and nurses plans it with you. Not every treatment is available in every hospital, so ask your team what is available and where.
Surgery
- Partial hepatectomy: an operation to remove the part of the liver that contains the cancer. It is possible only when the tumour can be removed safely and enough healthy liver is left. The remaining liver can regrow.
- Liver transplant: replaces the whole liver with a healthy donor liver. It may be an option for some people with early cancer that has not spread outside the liver, if a donor liver is available.
Ablation
Ablation destroys small tumours without removing them. A thin needle is passed through the skin into the tumour, guided by a scan, and the tumour is destroyed with heat (radiofrequency or microwave ablation), alcohol or freezing.
Embolisation
A thin tube is passed through a blood vessel, usually from the groin, into the artery that feeds the tumour, and tiny particles are used to block its blood supply. In chemoembolisation (TACE), chemotherapy is given directly into the tumour at the same time. It is used when the cancer is only in the liver but cannot be removed or ablated.
Radiotherapy
Radiotherapy uses high-energy rays to destroy cancer cells. Modern techniques, such as stereotactic body radiotherapy, aim precise, high doses at the tumour while protecting the rest of the liver.
Targeted therapy and immunotherapy
For advanced liver cancer, medicines that act on the whole body are used. Immunotherapy, such as atezolizumab with bevacizumab or durvalumab with tremelimumab, helps the immune system attack cancer cells. Targeted therapy tablets, such as sorafenib and lenvatinib, block signals that cancer cells need to grow. These medicines can control the cancer and help people live longer, but they do not usually cure it.
Treating the liver as well as the cancer
If you have hepatitis B or C, treating the infection is an important part of your care, alongside treatment for the cancer.
Clinical trials
Clinical trials are research studies that test whether a new treatment, a new combination of treatments or a new way of giving an existing treatment works better than current care. Many of today’s standard treatments were first offered through clinical trials.
What taking part involves
- Every trial has eligibility criteria, such as the type and stage of cancer, previous treatment and general health.
- Trials must be approved by a research ethics committee and, for medicines, by the national regulator. In Nigeria this includes NAFDAC and a recognised health research ethics committee.
- You will be given written information and asked for your informed consent before you join. You can ask questions at any time.
- Taking part is voluntary. You can leave a trial at any point and still receive standard care.
Finding a trial
Your treating team is the best place to start, because they know your diagnosis and which trials could suit you. Trial registries list studies that are recruiting:
- Pan African Clinical Trials Registry (PACTR): trials taking place in African countries.
- WHO International Clinical Trials Registry Platform: one search across registries worldwide.
- ClinicalTrials.gov: a large international registry run by the US National Library of Medicine.
Living with and after treatment
Side effects
Side effects depend on the treatment. They may include:
- Pain, tiredness and a few weeks of recovery after surgery
- Fever, nausea and pain in the abdomen for a few days after embolisation, sometimes called post-embolisation syndrome
- High blood pressure, diarrhoea, tiredness and sore, red skin on the hands and feet with targeted therapy tablets
- Inflammation of healthy organs with immunotherapy, which can cause a rash, diarrhoea, breathlessness or changes in hormone levels
Tell your care team promptly about any new or worsening symptom, especially yellowing of the skin or eyes, confusion, vomiting blood or sudden swelling of the abdomen. Many side effects can be managed.
Looking after your liver
Avoid alcohol, and check with your doctor or pharmacist before taking any new medicine, herbal remedy or supplement, because some can harm the liver. If you take antiviral medicine for hepatitis B, take it every day as prescribed. When your appetite is poor, small, frequent meals may help.
Protecting your family
If you have hepatitis B, your partner, children and other people you live with can be tested and, if they are not already protected, vaccinated. This is a simple way to protect the people you love.
Follow-up
Liver cancer can come back, and a damaged liver can develop new tumours. You will have regular check-ups, blood tests and scans so that any change is found early.
Emotional support and comfort care
A liver cancer diagnosis can affect your mood, relationships, work and finances. Talking with family, friends and your care team can help. Palliative care, which relieves pain and other symptoms and supports you and your family, can be offered at any stage, alongside other treatment.
Questions to ask your care team
- What type of liver cancer do I have, and what stage is it?
- How well is the rest of my liver working?
- What is causing my liver damage, and does it need treatment too?
- What are my treatment options, and what is the aim of each one?
- Which treatments are available here, and where else could I go?
- What side effects should I expect, and who do I contact if I have them?
- Should my family be tested or vaccinated for hepatitis B?
- Is there a clinical trial that could be right for me?
- How often will I need check-ups and scans?
